769 Interim clinical and translational data from NTC-001, a phase I study to evaluate the non-engineered neoantigen-specific T cell product BNT221 in patients with advanced or metastatic melanoma

769 Interim clinical and translational data from NTC-001, a phase I study to evaluate the non-engineered neoantigen-specific T cell product BNT221 in patients with advanced or metastatic melanoma

Bibliographic Details
Main Authors: Matthijs D Linssen, Divya Lenkala, Brian McCarthy, Cynthia Nijenhuis, Kristen Balogh, Mark DeMario, Emily Jackson, Jessica SW Borgers, Victoria Kohler, Sebastian Hymson, Katya Esaulova, Joong Hyuk F Sheen, Olivia Finney, Sebastian Klobuch, Richard B Gaynor, John B Haanen, Marit MVan Buuren
Format: Article
Language:English
Published: BMJ Publishing Group 2023-11-01
Series:Journal for ImmunoTherapy of Cancer

Similar Items